Pluristem’s Off-The-Shelf Placenta-Derived Cell Therapies

Pluristem announced that its "off the shelf" placental stem cells will be the focus of upcoming talking at investor and medical conferences. The company Pluristem is currently in Phase I trials assessing its unique bio-reactor expanded placental stem cells for the treatment of critical limb ischemia. In contrast to other therapies that use the patient’s…